EX-15.3 10 dp36881_ex1503.htm EXHIBIT 15.3
Exhibit 15.3
 
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
The Board of Directors
AstraZeneca PLC
 
We consent to the incorporation by reference in the registration statements (No. 33-83774, No. 333-145848, No. 333-114165 and No. 333-171306) on Form F-3 and registration statements (No. 333-09060, No. 333-09062, No. 33-65362, No. 33-65366, No. 333-12310, No. 333-12426, No. 333-12428, No. 333-13328, No. 333-13918, No. 333-124689, No. 333-152767 and No. 333-170381) on Form S-8 of AstraZeneca PLC of our reports dated January 31, 2013 with respect to the consolidated statements of financial position of AstraZeneca PLC and subsidiaries as of December 31, 2012, 2011 and 2010, and the related consolidated statements of comprehensive income, changes in equity and cash flows for each of the years in the three-year period ended December 31, 2012, and the effectiveness of internal control over financial reporting as of December 31, 2012, which reports appear in the 2012 Annual Report on Form 20-F of AstraZeneca PLC.
 
 
/s/ KPMG Audit Plc
 
KPMG Audit Plc
 
London
United Kingdom
25 March 2013